Business
Cybin Inc (NEO:CYBN, NYSEAMERICAN:CYBN) is a drug development company with four active psychedelic clinical programs targeting Major Depressive Disorder, Alcohol Use Disorder and Therapy Resistant Psychiatric Disorders (CYB001, CYB003, CYB004, CYB005). But, it’s not just four molecules the company is testing, Cybin has […]